Scaffold hopping and optimization towards libraries of glycogen synthase kinase-3 inhibitors
- Bioorg Med Chem Lett. 2002 Jun 3;12(11):1525-8. doi: 10.1016/s0960-894x(02)00169-5.
- 1. Medicinal Chemistry Research, Novo Nordisk A/S, Novo Nordisk Park, DK-2760 Måløv, Denmark.
Using a virtual screening strategy based on a methodology derived from the CATS molecular descriptor, a novel compound class with inhibitory activity against the GSK-3 enzyme was identified through scaffold hopping. These compounds were readily synthesized, either by solid-phase or solution-phase chemistry. Compounds with inhibitory activity below 1 microM were identified.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: GSK-3Research Areas: Metabolic Disease